Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2010. Start Trial.
Date Value
November 02, 2026 9.821
October 30, 2026 9.931
October 29, 2026 9.902
October 28, 2026 9.571
October 27, 2026 9.540
October 26, 2026 9.563
October 23, 2026 9.182
October 22, 2026 9.305
October 21, 2026 7.834
October 20, 2026 7.443
October 19, 2026 7.443
October 16, 2026 7.484
October 15, 2026 7.518
October 14, 2026 7.384
October 13, 2026 7.384
October 12, 2026 7.461
October 09, 2026 7.280
October 08, 2026 7.406
October 07, 2026 7.415
October 06, 2026 7.415
October 05, 2026 7.368
October 02, 2026 7.465
October 01, 2026 7.306
September 30, 2026 7.718
September 29, 2026 7.718
Date Value
September 28, 2026 7.702
September 25, 2026 7.375
September 24, 2026 7.632
September 23, 2026 7.401
September 22, 2026 7.401
September 21, 2026 7.319
September 18, 2026 7.840
September 17, 2026 7.734
September 16, 2026 7.764
September 15, 2026 7.842
September 14, 2026 7.889
September 11, 2026 7.703
September 10, 2026 7.252
September 09, 2026 7.712
September 08, 2026 7.866
September 04, 2026 7.991
September 03, 2026 7.780
September 02, 2026 8.265
September 01, 2026 7.891
August 31, 2026 7.851
August 28, 2026 7.851
August 27, 2026 8.374
August 26, 2026 8.343
August 25, 2026 8.366
August 24, 2026 8.366

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Eli Lilly & Co. 33.08
Novo Nordisk A/S 5.437
Pfizer Inc. 1.823
Teva Pharmaceutical Industries Ltd. 6.234
Astellas Pharma, Inc. 2.403

Price to Book Value Related Metrics